Maartje van den Biggelaar/sanquin.nl
Aug 2, 2026, 08:27
Maartje van den Biggelaar: HemoTwin Opens Doors for Aspiring Researchers
Maartje van den Biggelaar, Head of Laboratory of Proteomics at Sanquin, Lecturer of Pharmaceutical Biotechnology at Utrecht University, shared a post on LinkedIn:
“Within the national phramework of HemoTwin, we are looking for 3 PhD students to advance precision hemostasis in congenital bleeding disorders and bleeding disorders of unknown cause using mass spectrometry-based proteomics.
Join our team!”
Stay updated with Hemostasis Today.
-
Aug 2, 2026, 23:07Akshat Jain: Redefining Hemophilia Readiness in Mexico
-
Aug 2, 2026, 16:24Satish Medakkar: The Importance of Early Recognition in Atypical Hemolytic Uremic Syndrome
-
Aug 2, 2026, 16:07Mirjavad Mammadov: Understanding the Thrombotic Paradox of Heparin Therapy
-
Aug 2, 2026, 15:49Munira Borhany: Advancing Equity in Women’s Hematological Care
-
Aug 2, 2026, 14:54Every Second Counts: How CPR and AEDs Can Save a Life – American Heart Association
-
Aug 2, 2026, 14:38New French Guidelines for Acquired Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Aug 2, 2026, 14:36Sankesh Mehta: Restoring Venous Patency Through Mechanical Thrombectomy
-
Aug 2, 2026, 14:17Douglas Tavares: How Do We Get More People To Donate?
-
Aug 2, 2026, 14:15Saleh Shamse Basha: Severe Neonatal Anemia – When the Analyzer Tells a Story Before the Slide Does